ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,609Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 189

$560K Total Retail Price of All Prescriptions

Rank: 13 out of 189

528 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 528 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

9% of this provider’s 528 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 9,684 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
LISINOPRIL 576 533 1 1
FUROSEMIDE 519 466 2 10
OMEPRAZOLE 494 352 3 3
LEVOTHYROXINE SODIUM 477 374 4 5
WARFARIN SODIUM 459 394 5 14
LOVASTATIN 405 306 6 21
TRAZODONE HCL 293 206 7 16
AMLODIPINE BESYLATE 284 254 8 4
HYDROCHLOROTHIAZIDE 281 263 9 8
SERTRALINE HCL 265 248 10 17
METOPROLOL TARTRATE 251 226 11 6
SIMVASTATIN 247 187 12 2
ATENOLOL 243 214 13 12
DONEPEZIL HCL 220 220 14 27
HYDROCODONE-ACETAMINOPHEN 216 131 S3 15 11
CITALOPRAM HBR 203 156 16 15
NAMENDA 182 182 17 49
GABAPENTIN 180 120 18 22
METFORMIN HCL 178 146 19 7
ALENDRONATE SODIUM 162 146 20 18
IBUPROFEN 121 46 21 34
ATORVASTATIN CALCIUM 115 97 22 9
RISPERIDONE 115 85 22 82
LANTUS 103 93 24 56
FLUTICASONE PROPIONATE 99 76 25 30
PANTOPRAZOLE SODIUM 99 54 25 58
FENOFIBRATE 91 67 27 36
METOPROLOL SUCCINATE 90 75 28 19
PRAVASTATIN SODIUM 85 55 29 13
PROPRANOLOL HCL 81 39 30 153
GLIPIZIDE 81 76 30 39
POTASSIUM CHLORIDE 78 67 32 61
ADVAIR DISKUS 77 53 33 42
PAROXETINE HCL 74 48 34 46
ALLOPURINOL 74 61 34 25
DILTIAZEM 24HR ER 73 73 36 68
CYMBALTA 73 38 36 59
BISOPROLOL FUMARATE 72 62 38 73
PROAIR HFA 71 35 39 35
TRAMADOL HCL 66 65 40 32
CYCLOBENZAPRINE HCL 66 14 R 40 90
TAMSULOSIN HCL 65 42 42 28
VERAPAMIL ER 65 58 42 72
LISINOPRIL-HYDROCHLOROTHIAZIDE 64 38 44 23
DIGOXIN 64 61 44 66
RANITIDINE HCL 61 54 46 26
MORPHINE SULFATE ER 58 0 S2 47 137
VENLAFAXINE HCL 58 30 47 125
LOSARTAN POTASSIUM 57 56 49 20
ETODOLAC 56 25 50 206
NEXIUM 55 34 51 62
CIPROFLOXACIN HCL 54 45 52 69
CLOPIDOGREL 53 52 53 48
ZOLPIDEM TARTRATE 53 26 53 24
MIRTAZAPINE 52 32 55 45
GLIPIZIDE ER 51 38 56 52
VENLAFAXINE HCL ER 50 47 57 104
LEVOFLOXACIN 50 40 57 109
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 4, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.